Iran-US tensions threaten a 15% oil price spike from a Strait of Hormuz disruption. Learn why global supply is vulnerable and what to watch next.
Editorial Team
·
Ohio aims to be a global biotech leader by 2030. See how $5B in VC funding and new facilities will drive its rise in health tech.
·
Accelevation's $7.2B Nasdaq IPO signals renewed investor appetite for tech in 2026. See key valuation details and what its success means for future growth.
·
New EU rules could let gene-edited crops reach market by 2026. Learn how science-backed changes boost food security and sustainability.
·
Health spending isn't just a cost. Learn how every dollar invested in global health yields up to $20, preventing a $12T economic loss.
·
·
6 min read
Gene editing's future hinges on complex CRISPR patent disputes. See how IP battles, varied laws, and licensing shape biotech's next decade.
·
·
8 min read
NIH funds $150M for new CRISPR delivery methods. See how viral and non-viral systems improve gene editing, making therapies safer and more effective.
·
·
6 min read
Why do new WHO drugs struggle to reach many nations? Learn about funding gaps, distribution hurdles, and what's needed by 2026.
·
·
8 min read
Oil markets hedged $15B in Q1 2026 due to Iran. Learn why producers fear supply disruptions and what to watch next in the Strait of Hormuz.
·
·
6 min read
US-Iran tensions flare in Hormuz, raising oil prices 3%. Understand the 2026 crisis, its impact on global trade, and diplomatic efforts to de-escalate.
·
·
6 min read
